Skip to content

Incyte

US · INCY #803 by market cap Listed 1970
114.63 -1.25 -1.07%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Incyte

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Founded
1991
CEO
Mr. William Meury
Employees
2,844
Headquarters
Wilmington, Delaware, United States of America
Fiscal year end
12-31
Website
incyte.com

Company profile

Exchange
US
Symbol
INCY
Market-cap rank
#803
Listing date
1970-01-01
Market cap
23.36B
Float cap
19.70B
Shares out
203.83M
Float shares
171.89M

Sectors & themes

Biotechnology CAR-T Therapy ARK Portfolio Global medical industry Regular Savings Plan Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.

Incyte discussion 0 comments

Add a comment